gastroparesis

in review 5 min read Updated 2026-11-19
gastroparesis

Symptoms (nausea, vomiting, early satiety, fullness) + objectively delayed gastric emptying + no mechanical obstruction. All three are needed: upper endoscopy is mandatory to exclude obstruction, then a 4-hour solid-meal scintigraphy (or breath test), off opioids, cannabinoids, prokinetics and antiemetics for 48 h. Food in the stomach at endoscopy is not a diagnosis. Common causes: diabetes, post-surgical (fundoplication, bariatric, vagotomy), idiopathic, opioids. Treatment: glucose control, small-particle low-fat diet, stop slowing drugs, then metoclopramide (≤12 weeks, warn about tardive dyskinesia) or domperidone (check QTc), antiemetics for symptoms. No tricyclics or other neuromodulators, no pyloric botulinum toxin. Refractory → GI motility referral (G-POEM, gastric electrical stimulation), with weight-loss → nutrition support and screening for an eating disorder.


diagnosis needs three things

flowchart TD
  A[chronic nausea, vomiting, early satiety, fullness] --> B[EGD ± imaging: exclude obstruction, ulcer, malignancy]
  B -->|obstruction or other cause| X[treat that]
  B -->|normal| C[stop opioids, cannabinoids, prokinetics, antiemetics 48 h; glucose controlled on test day]
  C --> D[solid-meal scintigraphy ≥3 h, ideally 4 h · or 13C-spirulina breath test]
  D -->|retention >10% at 4 h| E[gastroparesis]
  D -->|normal emptying| F[functional dyspepsia / chronic nausea-vomiting syndromes]
  • endoscopy first (UEG grade A): obstruction, peptic ulcer and malignancy look the same. Retained food at endoscopy suggests the diagnosis but doesn’t make it; small bowel obstruction can be excluded on imaging
  • scintigraphy is the standard test (ACG strong): a 2-hour study misses cases; 4-hour retention >10% defines delay. Breath testing is a validated alternative; wireless motility capsule is an option (ACG) but not endorsed by UEG. Radiopaque markers and gastric ultrasound: no
  • hyperglycaemia slows emptying on its own: test with glucose controlled, or the result over-calls gastroparesis
  • gastroparesis and functional dyspepsia overlap: on repeat scintigraphy ~40% of patients switch label (delayed ↔ normal) with the same symptoms. Emptying rate correlates poorly with symptoms, which is why drugs that speed emptying don’t reliably help, though ACG notes the label still matters for prognosis (functional dyspepsia does better; gastroparesis tends to persist)
  • weight loss → exclude an eating disorder (UEG); avoidant/restrictive food intake is common in gastroparesis cohorts. Also think of cannabinoid hyperemesis (hot showers, daily use) and rumination before calling it gastroparesis

causes

causepoint
diabetes (type 1 > type 2)autonomic neuropathy; acute hyperglycaemia worsens it; often with other microvascular disease
post-surgicalfundoplication or hiatal hernia repair (vagal injury), bariatric, partial gastrectomy
drugsopioids most of all; cannabinoids, anticholinergics
neurologicalParkinson’s, multiple sclerosis, amyloid neuropathy
connective tissue diseasesystemic sclerosis
idiopathiclargest group; some follow a viral illness

management

first line, every patient

  • glycaemic control in diabetes (ACG conditional): acute hyperglycaemia itself delays emptying
  • small-particle, low-fat diet: small, frequent meals; solids well chewed or blended; liquids empty better than solids (ACG conditional; RCT in diabetic gastroparesis improved symptoms and emptying)
  • remove the slowing drugs: opioids first; reconsider GLP-1 receptor agonists and anticholinergics
  • correct dehydration, electrolytes and nutritional deficiencies

drugs

drugrolewatch
metoclopramide (D₂ antagonist + prokinetic)suggested over no treatment for refractory symptoms (ACG conditional, low certainty); D₂ antagonists endorsed by UEG; ≤10 mg TID–QID before meals (regulators restrict higher doses)tardive dyskinesia (~0.1 per 1000 patient-years in recent data; higher in older women, diabetes, renal/liver failure, with antipsychotics); regulators limit to ≤12 weeks and caution over 65; stop at the first involuntary movement
domperidone (peripheral D₂ antagonist)alternative where available (Canada)QTc prolongation: baseline ECG, avoid with QT drugs/CYP3A4 inhibitors; few extrapyramidal effects
erythromycin (motilin agonist)short courses (1–4 weeks) (ACG; UEG didn’t endorse motilin agonists)tachyphylaxis, antibiotic resistance; a meta-analysis found no excess arrhythmia or CV death with macrolides (ACG)
prucalopride (5-HT₄ agonist)option (ACG, UEG); best data in idiopathicinconsistent symptom benefit
antiemetics (ondansetron, prochlorperazine)symptom control (ACG conditional; UEG didn’t endorse — no formal trials)don’t speed emptying
  • not recommended: tricyclics and other central neuromodulators (ACG strong; nortriptyline RCT in idiopathic gastroparesis, n=130, negative; UEG reached no consensus either way), haloperidol, ghrelin agonists, herbal products. PPIs treat coexisting reflux (GERD overlaps in >50%), not gastroparesis (UEG 0% agreement as first-line)
  • opioid-induced or palliative gastric stasis: metoclopramide is standard → palliative symptom management

refractory

  • pyloric botulinum toxin: no (ACG strong): RCTs negative
  • pyloromyotomy (G-POEM or surgical): suggested for symptoms refractory to medical therapy (ACG conditional, low certainty; mostly open-label, UEG: 28% agreement on efficacy)
  • gastric electrical stimulation: for medically refractory diabetic or idiopathic gastroparesis (ACG conditional, humanitarian device; mixed crossover trials; UEG didn’t endorse)
  • nutrition: severe weight loss or intractable vomiting → enteral (jejunal) or parenteral support (UEG); in a systematic review, PEG with jejunal extension had fewer symptoms than other enteral routes, and keeping some oral intake is the goal. Watch for refeeding syndrome
  • prognosis depends on the cause (UEG): in a US cohort, an infectious prodrome, male sex and age >50 predicted improvement at 48 weeks; obesity, smoking, pain modulators and moderate–severe abdominal pain predicted persistence

Prepared 2026-11-19. Not yet verified — check every number against the sources.

Key references

Suggest a correction gastroparesis